

Genomix Molecular Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.52 M
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.90 M
- Revenue Growth -9.34%
- Profit Growth 79.93%
- Ebitda 102.03%
- Net Worth -1.61%
- Total Assets -27.54%
About Genomix Molecular Diagnostics
Genomix Molecular Diagnostics Private Limited (GMDPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 January 2007 and has a history of 18 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.52 M.
The company currently has active open charges totaling ₹2.90 M.
Bilhan Polavarapu, Vijay Kanthamneni, and Rathnagiri Polavarapu serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85110TG2007PTC052224
- Company No.
052224
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Genomix Molecular Diagnostics Private Limited offer?
Genomix Molecular Diagnostics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Rapid Test Kit.
Who are the key members and board of directors at Genomix Molecular Diagnostics?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bilhan Polavarapu ![]() | Director | 18-Aug-2021 | Current |
Vijay Kanthamneni ![]() | Director | 03-Jan-2007 | Current |
Rathnagiri Polavarapu ![]() | Director | 03-Jan-2007 | Current |
Financial Performance of Genomix Molecular Diagnostics.
Genomix Molecular Diagnostics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.34% decrease. The company also saw a substantial improvement in profitability, with a 79.93% increase in profit. The company's net worth dipped by a decrease of 1.61%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Genomix Molecular Diagnostics?
In 2023, Genomix Molecular Diagnostics had a promoter holding of 97.12% and a public holding of 2.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Genomix Healthcare (India) Private Limited
Rathnagiri Polavarapu is a mutual person
- Genomix Carl Private Limited
Bilhan Polavarapu and Rathnagiri Polavarapu are mutual person
Charges (Loans)
₹2.90 M
₹0
Charges Breakdown by Lending Institutions
- Department Of Biotechnology : 0.29 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
07 Sep 2009 | Department Of Biotechnology | ₹2.90 M | Open |
How Many Employees Work at Genomix Molecular Diagnostics?
Genomix Molecular Diagnostics has a workforce of 7 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Genomix Molecular Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomix Molecular Diagnostics's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Genomix Molecular Diagnostics
Recent activity within the organization
- Annual General Meeting
Genomix Molecular Diagnostics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Genomix Molecular Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Bilhan Kavikishore Polavarapu was appointed as a Director was appointed as a Director on 18 Aug 2021 & has been associated with this company since 3 years 7 months .
- Charges
A charge with Department Of Biotechnology amounted to Rs. 2.90 M with Charge ID 10175699 was registered on 07 Sep 2009.
- Director Appointment
Vijay Kumar Kanthamneni was appointed as a Director was appointed as a Director on 03 Jan 2007 & has been associated with this company since 18 years 2 months .
- Director Appointment
Rathnagiri Polavarapu was appointed as a Director was appointed as a Director on 03 Jan 2007 & has been associated with this company since 18 years 2 months .
Frequently asked questions
What is the Incorporation or founding date of Genomix Molecular Diagnostics Private Limited?
Genomix Molecular Diagnostics Private Limited was incorporated on 03 Jan 2007.
What is authorized share capital and paid-up capital of Genomix Molecular Diagnostics Private Limited?
The authorized share capital of Genomix Molecular Diagnostics Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.52 M.
Who are the current board members & directors of Genomix Molecular Diagnostics Private Limited?
Currently 3 directors are associated with Genomix Molecular Diagnostics Private Limited.
- Bilhan Kavikishore Polavarapu
- Vijay Kumar Kanthamneni
- Rathnagiri Polavarapu
What is the registered address of Genomix Molecular Diagnostics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Genomix Molecular Diagnostics Private Limited is D.No.5-36/207 Prashanth Nagar, Kukatpally India, Hyderabad, Telangana, 500072.
What is the corporate identification number (CIN) and company number of Genomix Molecular Diagnostics Private Limited?
The corporate identification number (CIN) of Genomix Molecular Diagnostics Private Limited is U85110TG2007PTC052224 and the company number is 052224 as per Ministry of Corporate Affairs (MCA).
What is the official website of Genomix Molecular Diagnostics Private Limited?
The Official website of Genomix Molecular Diagnostics Private Limited is https://www.genomixbiotech.com
What has been the recent revenue trend for Genomix Molecular Diagnostics Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Genomix Molecular Diagnostics Private Limited has fallen by -9.34%.
How many employees does Genomix Molecular Diagnostics Private Limited currently have?
As Per 2023 financial reports, 7 employees are currently employed by Genomix Molecular Diagnostics Private Limited.
What change has been observed in the net worth of Genomix Molecular Diagnostics Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Genomix Molecular Diagnostics Private Limited has experienced an downturn of -1.61%.
What are the total open charges for Genomix Molecular Diagnostics Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Genomix Molecular Diagnostics Private Limited amount to ₹ 2.90 M.
When was the last Balance Sheet of Genomix Molecular Diagnostics Private Limited filed with the ROC?
The most recent Balance Sheet for Genomix Molecular Diagnostics Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
OP
Ojasvi PolavarapuDirectorKK
Krishnakishore KotaDirector